NCT03024151 The Effects of T4 Versus T4/T3 on Psychological Distress After Total Thyroidectomy in Thyroid Cancer Patients Status COMPLETED Phase NA
NCT03006289 Relationship of Metabolic Syndrome and Its Components With Thyroid Cancer Status UNKNOWN Phase N/A
NCT02988817 Enapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT02953288 Differential Diagnosis and Clinical Treatment Strategies of Thyroid Nodules. Status UNKNOWN Phase N/A
NCT02947399 Comparison of I-124 and I-131 Radiopharmacokinetics in DTC Patients With Thyroid Hormone Withdrawal Status TERMINATED Phase NA
NCT02947035 Molecular Testing to Direct Extent of Initial Thyroid Surgery Status COMPLETED Phase PHASE2
NCT02946918 Levothyroxine Replacement With Liquid Gel Capsules vs Tablets Post-thyroidectomy Status TERMINATED Phase PHASE4
NCT02938702 Active Surveillance on Papillary Thyroid Microcarcinoma Status ACTIVE_NOT_RECRUITING Phase N/A
NCT02911155 Cancer and Other Disease Risks in U.S. Nuclear Medicine Technologists Status COMPLETED Phase N/A
NCT02862470 Anaplastic Thyroid Cancer and Follicular Thyroid Cancer-derived Exosomal Analysis Via Treatment of Lovastatin and Vildagliptin and Pilot Prognostic Study Via Urine Exosomal Biological Markers in Thyroid Cancer Patients Status COMPLETED Phase N/A
NCT02731352 Study of Apatinib in Patients With Differentiated Thyroid Cancer Status COMPLETED Phase PHASE2
NCT02726282 Impact of Papillary Microcarcinoma Terminology on Patients Treatment Preferences: a Cross Sectional Survey Status WITHDRAWN Phase N/A
NCT02724176 Potential Role for Carbon Nanoparticles to Guide Central Neck Dissection in Patients With Papillary Thyroid Cancer Status COMPLETED Phase NA
NCT02702388 A Trial of Lenvatinib (E7080) in Subjects With Iodine-131 Refractory Differentiated Thyroid Cancer to Evaluate Whether an Oral Starting Dose of 18 Milligram (mg) Daily Will Provide Comparable Efficacy to a 24 mg Starting Dose, But Have a Better Safety Profile Status COMPLETED Phase PHASE2
NCT02658513 Evaluation of Lancet Blood Sampling for Radioiodine Dosimetry in Thyroid Cancer Status COMPLETED Phase N/A